Neurodevelopmental origins of bipolar disorder: IPSC models

Molecular and Cellular Neuroscience

Volumn 73, Issue , 2016, Pages 63-83

  O'Shea, K Sue ^a,b   McInnis, Melvin G ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Astrocyte; Autism; Cortex; Depression; Development; Epigenetics; Gene expression; Glia; Mania; Microarray; Mood disorder; Neuron; Oligodendrocyte; Schizophrenia; Stem cell; Telencephalon

Indexed keywords

PROTEIN NODAL; SONIC HEDGEHOG PROTEIN; TRANSCRIPTOME;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BRAIN CELL; CALCIUM SIGNALING; CELL MIGRATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HISTONE METHYLATION; HUMAN; INDUCED PLURIPOTENT STEM CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TELENCEPHALON; WNT SIGNALING PATHWAY; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES;

BIPOLAR DISORDER; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; NEUROGENESIS; TRANSCRIPTOME;

EID: 84960897694     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.11.006     Document Type: Review

References (364)

1. Abdolmaleky H.M., Zhou J.R., Thiagalingam S. An update on the epigenetics of psychotic diseases and autism. Epigenomics 2015, 7:427-449.
2. Abe N., Uchida S., Otsuki K., Hobara T., Yamagata H., Higuchi F., Shibata T., Watanabe Y. Altered sirtuin deacetylase gene expression in patients with a mood disorder. J. Psychiatr. Res. 2011, 45:1106-1112.
3. Abolitz F., Zamorano F. Neural progenitors, patterning and ecology in neocortical origins. Front. Neuroanat. 2013, 7:38.
4. Adler C.M., Adams J., DelBello M.P., Holland S.K., Schmithorst V., Levine A., Jarvis K., Strakowski S.M. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. Am. J. Psychiatry 2006, 163:322-324.
5. Aifragis P., Liapi A., Parnavelas J.G. Lhx6 regulates the migration of cortical interneurons from the ventral Telencephalon but does not specify their GABA phenotype. J. Neurosci. 2004, 24:5643-5648.
6. Akula N., Barb J., Jiang X., Wendland J.R., Choi K.H., Sen S.K., Hou L., Chen D.T.W., Laje G., Johnson K., Lipska B.K., Kleinman J.E., Corrada-Bravo H., Detera-Wadleigh S., Munson P.J., McMahon F.J. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol. Psychiatry 2014, 19:1179-1185.
7. Aberg K.A., Xie L.Y., Mcclay J.L., Nerella S., Vunck S., Snider S., Beardsley P.M., van den Oord E.J. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics 2013, 5:367-377.
8. Altshuler L.L., Townsend J.D. Functional Brain Imaging in Bipolar Disorder. The Bipolar Brain. Integrating Neuroimaging and Genetics 2012, 53-77. Oxford University Press, New York. S.M. Strakowski (Ed.).
9. Amano K., Yamada K., Iwayama Y., Detera-Wadleigh S.D., Hattori E., Toyota T., Tokunaga K., Yoshikawaa T., Yamakawa K. Association study between the down syndrome cell adhesion molecule (DSCAM) gene and bipolar disorder. Psychiatr. Genet. 2008, 18:1-10.
10. Ament S.A., Szelinger S., Glusman G., Ashworth J., Hou L., Akula N., Shekhtman T., Badner J.A., Brunkow M.E., Mauldin D.E., Stittrich A.B., Rouleau K., Detera-Wadleigh S.D., Nurnberger J.I., Edenberg H.J., Gershon E.S., Schork N., Bipolar Genome Study, Price N.D., Gelinas R., Hood L., Craig D., McMahon F.J., Kelsoe J.R., Roach J.C. Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:3576-3581.
11. Andreazza A.C., Wang J.F., Salmasi F., Shao L., Young L.T. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J. Neurochem. 2013, 127:552-561.
12. Andrews P.S. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 1984, 103:285-293.
13. Andrews P.W. Teratocarcinomas and human embryology: pluripotent human EC cell lines. APMIS 1998, 106:158-167.
14. Angst J., Sellaro R. Historical and natural history of bipolar disorder. Biol. Psychiatry 2000, 48:445-457.
15. Arango C., Fraquas D., Parellada M. Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr. Bull. 2014, S2:S138-S146.
16. Arnone D., Cavanagh J., Gerber D., Lawrie S.M., Ebmeier K.P., McInosh A.M. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br. J. Psychiatry 2009, 195:194-201.
17. Atmaca M., Ozdemir H., Yildirim H. Corpus callosum areas in first-episode patients with bipolar disorder. Psychol. Med. 2007, 37:699-704.
18. Au E., Ahmed T., Karayannis T., Biswas S., Gan L., Fishell G. A modular gain-of-function approach to generate cortical interneuron subtypes from ES cells. Neuron 2013, 80:1145-1158.
19. Bardy C., van den Hurk M., Eames T., Marchand C., Hernandez R.V., Kellogg M., Gorris M., Galet B., Palomares V., Brown J., Bang A.G., Mertens J., Böhnke L., Boyer L., Simon S., Gage F.H. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E2725-E2734.
20. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehár J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jané-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A. The cancer cell line encyclopedia enables predictive modeling of anticancer drug sensitivity. Nature 2012, 483:603-607.
21. Bashir S., Zeina R., Muhammad D., Al-Ayadhi L. Role of hedgehog protein family members in autistic children. Neurol. Psychiatry Brain Res. 2014, 20:63-67.
22. Baudoin J.P., Viou L., Launay P.S., Luccardini C., Espeso Gil S., Kiyasova V., Irinopoulou T., Alvarez C., Rio J.P., Boudier T., Lechaire J.P., Kessaris N., Spassky N., Métin C. Tangentially migrating neurons assemble a primary cilium that promotes their reorientation to the cortical plate. Neuron 2012, 76:1108-1122.
23. Bavamian S., Mellios N., Lalonde J., Fass D.M., Wang J., Sheridan S.D., Madison J.M., Zhou F., Rueckert E.H., Barker D., Perlis R.H., Sur M., Haggarty S.J. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol. Psychiatry 2015, 20:573-584.
24. Bearden C.E., Glahn D.C., Caetano S., Olvera R.L., Fonseca M., Najt P., Hunter K., Pliszka S.R., Soares J.C. Evidence for disruption in prefrontal cortical functions in juvenile bipolar disorder. Bipolar Disord. 2007, 9(S1):145-159.
25. Bearden C.E., Hoffman K.M., Cannon T.D. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord. 2001, 3:106-150.
26. Bearden C.E., Thompson P.M., Dalwani M., Hayashi K.M., Lee A.D., Nicoletti M., Trakhtenbroit M., Glahn D.C., Brambilla P., Sassi R.B., Mallinger A.G., Frank E., Kupfer D.J., Soares J.C. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol. Psychol. 2007, 62:7-16.
27. Bearden C.E., van Erp T.G., Dutton R.A., Boyle C., Madsen S., Luders E., Kieseppa T., Tuulio-Henriksson A., Huttunen M., Partonen T., Kaprio J., Lönnqvist J., Thompson P.M., Cannon T.D. Mapping corpus callosum morphology in twin pairs discordant for bipolar disorder. Cereb. Cortex 2011, 21:2415-2424.
28. Beckmann H., Jakob H. Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses?. J. Neural Transm. Gen. Sect. 1991, 84:155-164.
29. Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat. Rev. Neurosci. 2002, 3:728-739.
30. Ben-Ari Y., Woodin M.A., Sernagor E., Cancedda L., Vinay L., Rivera C., Legendre P., Luhmann H.J., Bordey A., Wenner P., Fukuda A., van den Pol A.N., Gaiarsa J.-L., Cherubini E. Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!. Front. Cell. Neurosci. 2012, 6:1-18.
31. Benes F.M. Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropsychopharmacology 2011, 60:1232-1242.
32. Benes F.M., Lim B., Subburaju S. Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11731-11736.
33. Benes F.M., Matzilevich D., Burke R.E., Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 2006, 11:241-251.
34. Benes F.M., Vincent S.L., Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 2001, 50:395-406.
35. Beveridge N.J., Santarelli D.M., Wang X., Tooney P.A., Webster M.J., Weickert C.S., Cairns M.J. Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression. Schizophr. Bull. 2014, 40:399-409.
36. Blennow G., McNeil T.F. Neurological deviations in newborns at psychiatric high risk. Acta Psychiatr. Scand. 1991, 84:179-184.
37. Blond B.N., Fredericks C.A., Blumberg H.P. Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system. Bipolar Disord. 2012, 14:340-355.
38. Blumberg H.P., Kaufman J., Martin A., Whiteman R., Zhang J.H., Gore J.C., Charney D.S., Krystal J.H., Peterson B.S. Amygdala and Hippocampal volumes in adolescents and adults with bipolar disorder. Arch. Gen. Psychiatry 2003, 60:1201-1208.
39. Boccardi M., Almici M., Bresciani L., Caroli A., Bonetti M., Monchieri S., Gennarellli M., Frisoni G.B. Clinical and medial temporal features in a family with mood disorders. Neurosci. Lett. 2010, 468:93-97.
40. Bootsman F., Brouwer R.M., Schnack H.G., van Baal G.C.M., van der Schot A.C., Vonk R., Hulshoff Pol H.E., Nolen W.A., Kahn R.S., van Haren N.E.M. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychol. Med. 2015, 45:193-204.
41. Bora E., Fornito A., Yücel M., Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol. Psychiatry 2010, 67:1097-1105.
42. Bowie C.R., Depp C., McGrath J.A., Wolyniec P., Mausbach B.T., Thornquist M.H., Luke J., Patterson T.L., Harvey P.D., Pulver A.E. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am. J. Psychiatry 2010, 167:1116-1124.
43. Brady R.O., McCarthy J.M., Prescot A.P., Jensen J.E., Cooper A.J., Cohen B.M., Renshaw P.F., Ongür D. Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder. Bipolar Disord. 2013, 15:434-439.
44. Brennand K., Savas J.N., Kim Y., Tran N., Simone A., Hashimoto-Torii K., Beaumont K.G., Kim H.J., Topol A., Ladran I., Abdelrahim M., Matikainen-Ankney B., Chao S.-h., Mrksich M., Rakic P., Fang G., Zhang B., Yates J.R., Gage F.H. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 2014, 20:361-368.
45. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
46. Briscoe J., Sussel L., Serup P., Hartigan-O'Connor D., Jessell T.M., Rubenstein J.L., Ericson J. Homeobox gene Nkx2.2 and specification of neuronal identity by graded sonic hedgehog signalling. Nature 1999, 398:622-627.
47. Buka S.L., Fan A.P. Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia. Schizophr. Res. 1999, 39:113-119.
48. Burdick K.E., Haggarty S.J., Perlis R. The neurobiology of bipolar disorder. Neurobiology of Mental Illness 2013, 355-364. Oxford University Press, New York. D.S. Charney, J.D. Buxbaum, P. Sklar, E.J. Nestler (Eds.).
49. Buttner N., Bhattacharyya S., Walsh J., Benes F.M. DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr. Res. 2007, 93:33-41.
50. Caballero I.M., Manuel M.H., Molinek M., Quintana-Urzainqui I., Mi D., Shimogori T., Price D.J. Cell-autonomous repression of Shh by the transcription factor Pax6 regulates diencephalic patterning by controlling the central diencephalic organizer. Cell Rep. 2014, 8:1405-1418.
51. Caetano S.C., Silveira C.M., Kaur S., Nicoletti M., Hatch J.P., Bramilla P., Sassi R., Axelson D., Keshavan M.S., Ryan N.D., Birmaher B., Soares J.C. Abnormal corpus callosum myelination in pediatric bipolar patients. J. Affect. Disord. 2008, 108:297-301.
52. Casey B.J., Getz S., Galvan A. The adolescent brain. Dev. Rev. 2008, 28:62-77.
53. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
54. Chanda S., Ang C.E., Davila J., Pak C.H., Mall M., Lee Q.Y., Ahlenius H., Jung S.W., Sudhof T.C., Wernig M. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep. 2014, 3:282-296.
55. Chen B.K., Sassi R., Axelson D., Hatch J.P., Sanches M., Nicoletti M., Brambilla P., Keshavan M.S., Ryan N.D., Birmaher B., Soares J.C. Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol. Psychiatry 2004, 56:399-405.
56. Chen H.M., DeLong C.J., Bame M., Rajapakse I., Herron T.J., McInnis M.G., O'Shea K.S. Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transcult. Psychiatry 2014, 4.
57. Chen J., Lin M., Hrabovsky A., Pedrosa E., Dean J., Jain S., Zheng D., Lachman H.M. ZNF804A transcriptional networks in differentiating neurons derived from induced pluripotent stem cells of human origin. PLoS One 2015, 10.
58. Chen W.Y., Liu S.Y., Chang Y.S., Yin J.J., Yeh H.L., Mouhieddine T.H., Hadadeh O., Abou-Kheir W., Liu Y.N. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget 2015, 6:441-457.
59. Choi K.H., Higgs B.W., Wendland J.R., Song J., McMahon F.J., Webster M.J. Gene expression and genetic variation data implicate PCLO in bipolar disorder. Biol. Psychiatry 2011, 69:353-359.
60. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., Myers R.M., Bunney W.E., Akil H., Watson S.J., Jones E.G. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15653-15658.
61. Christensen M.V., Kyvik K.O., Kessing L.V. Cognitive function in unaffected twins discordant for affective disorder. Psychol. Med. 2006, 36:1119-1129.
62. Chudal R., Sourander A., Polo-Kantola P., Hinkka-Yli-Salomäki S., Lehti V., Sucksdorff D., Gissler M., Brown A.S. Perinatal factors and the risk of bipolar disorder in Finland. J. Affect. Disord. 2014, 155:75-80.
63. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2011, 29:311-324.
64. Coebergh J.A., Fransen van de Putte D.E., Snoeck I.N., Ruivenkamp C., van Haeringen A., Smit L.M. A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. Eur. J. Paediatr. Neurol. 2014, 18:413-415.
65. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 2001, 8:723-742.
66. Cotter D., Hudson L., Landau S. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord. 2005, 7:358-369.
67. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
68. Craddock N., Sklar P. Genetics of bipolar disorder. Lancet 2013, 381:1654-1662.
69. Cruceanu C., Alda M., Grof P., Rouleau G.A., Tureccki G. Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder. PLoS One 2012, 7.
70. Cruceanu C., Freemantle E., Alda M., Rouleau G.A., Turecki G. H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Neuropsychopharmacology 2013, 16:289-299.
71. Darby M.M., Sabunciyan S. Repetitive elements and epigenetic marks in behavior and psychiatric disease. Adv. Genet. 2014, 86:185-252.
72. Davies M.N., Volta M., Pidsley R., Lunnon K., Dixit A., Lovestone S., Coarfa C., Harris R.A., Milosavljevic A., Troakes C., Al-Sarraj S., Dobson R., Schalkwyk L.C., Mill J. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012, 13:R43.
73. DelBello M.P., Adler C.M., Strakowski S.M. The neurophysiology of childhood and adolescent bipolar disorder. CNS Spectr. 2006, 11:298-311.
74. DelBello M.P., Geller B. Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord. 2001, 3:325-334.
75. DelBello M.P., Zimmerman M.E., Mills N.P., Getz G.E., Strakowski S.M. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord. 2004, 6:43-52.
76. Demjaha A., MacCabe J.H., Murray R.M. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr. Bull. 2012, 38:209-214.
77. Dempster E.L., Pidsley R., Schalkwyk L.C., Owens S., Georgiades A., Kane F., Kalidindi S., Picchioni M., Kravariti E., Toulopoulou T., Murray R.M., Mill J. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2011, 20:4786-4796.
78. Dong E., Ruzicka W.B., Grayson D.R., Guidotti A. DNA-methyltransferase (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophr. Res. 2014, doi:10.1016/j.schres.2014.10.030.
79. Dong X.H., Zhen X.C. Glial pathology in bipolar disorder: potential therapeutic implications. CNS Neurosci. Ther. 2015, 21:393-397.
80. Duan J., Shi J., Fiorentino A., Leites C., Chen X., Moy W., Chen J., Alexandrov B.S., Usheva A., He D., Freda J., O'Brien N.L., Genomic Psychiac Cohort consortium, McQuillin A., Sanders A.R., Gershon E.S., DeLisi L.E., Bishop A.R., Gurling H.M., Pato M.T., Levinson D.F., Kendler K.S., Pato C.N., Gejman P.V. A rare functional noncoding variant at the GWAS-implicated MIR137/MiR 2682 locus might confer risk to schizophrenia and bipolar disorder. Am. J. Hum. Genet. 2014, 95:744-753. Molecular Genetics of Schizophrenia collaboration.
81. Duffy A., Horrocks J., Doucette S., Keown-Stoneman C., McCloskey S., Grof P. The developmental trajectory of bipolar disorder. Br. J. Psychiatry 2014, 204:122-128.
82. Edwards M.K., McBurney M.W. The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev. Biol. 1983, 98:187-191.
83. Efthymiou A.G., Chen G., Rao M., Chen G., Boehm M. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. Expert. Opin. Biol. Ther. 2014, 14:1333-1344.
84. Eisner A., Pazyra-Murphy M.F., Durresi E., Zhou P., Zhao X., Chadwick E.C., Xu P.X., Hillman R.T., Scott M.P., Greenberg M.E., Segal R.A. The Eya1 phosphatase promotes Shh signaling during hindbrain development and oncogenesis. Dev. Cell 2015, 33:22-35.
85. Ek M., Wicks S., Svensson A.C., Dalman C. Advancing paternal age and schizophrenia: the impact of delayed fatherhood. Schizophr. Bull. 2015, 41:708-714.
86. Ellison-Wright I., Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr. Res. 2010, 117:1-12.
87. Faedda G.L., Marangni C., Serra G., Salvatore P., Sani G., Vazquez G.H., Tondo L., Girardi P., Baldessarini R.J., Koukopoulos A. Precursors of bipolar disorders: a systematic literature review of prospective studies. J. Clin. Psychiatry 2015, 76:614-624.
88. Faedda G.L., Serra G., Marangoni C., Salavatore P., Sani G., Vazquez G.H., Tondo L., Girardi P., Baldessarini R.J., Koukopoulos A. Clinical risk factors for bipolar disorders: a systematic review of prospective studies. J. Affect. Disord. 2014, 168:3114-3121.
89. Farrow T.F., Whitford T.J., Williams L.M., Gomes L., Harris A.W. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol. Psychiatry 2005, 58:713-723.
90. Fass D.M., Schroeder F.A., Perlis R.H., Haggarty S.J. Epigenetic mechanisms in mood disorders: targeting neuroplasticity. Neuroscience 2013, 264:112-130.
91. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St.C.D., Robinson M., van Bek M., Pereira A.C., Kandaswarmy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
92. Flandin P., Zhao Y., Vogt D., Jeong J., Long J., Potter G., Westphal H., Rubenstein J.L.R. Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors. Neuron 2011, 70:939-950.
93. Florio M., Huttner W.B. Neural progenitors, neurogenesis and the evolution of the neocortex. Development 2014, 141:2184-2194.
94. Foland L.C., Altshuler L.L., Sugar C.A., Lee A.D., Leow A.D., Townsend J., Narr K.L., Asuncion D.M., Toga A.W., Thompson P.M. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport 2008, 19:221-224.
95. Folsom T.D., Fatemi S.H. The involvement of reelin in neurodevelopmental disorders. Neuropharmacology 2013, 68:122-135.
96. Fotuhi M., Do D., Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat. Rev. Neurol. 2012, 8:189-202.
97. Frans E.M., Sandin S., Reichenberg A., Lichtenstein P., Langstrom N., Hultman C.M. Advancing paternal age and bipolar disorder. Arch. Gen. Psychiatry 2008, 65:1034-1040.
98. Frazier J.A., Breeze J.L., Makris N., Giuliano A.S., Herbert M.R., Seidman L., Biederman J., Hodge S.M., Dieterich M.E., Gerstein E.D., Kennedy D.N., Rauch S.L., Cohen B.M., Caviness V.S. Cortical gray matter differences identified by structural magnetic resonance imaging in pediatric bipolar disorder. Bipolar Disord. 2005, 7:555-569.
99. Galli R., Fiocco R., De Filipis L., Muzio L., Gritti A., Mercurio S., Broccoli V., Pellegrini M., Mallamaci A., Vescovi A. EMX2 regulates the proliferation of stem cells of the adult mammalian nervous system. Development 2002, 129:1633-1644.
100. Gao Y., Galante M., El-Mallakh J., Nurnberger J.I., Delamere N.A., Lei Z., El-Mallakh R.S., BiGS Consortium BDNF expression in lymphoblastoid cell lines carrying BDNF SNPs associated with bipolar disorder. Psychiatr. Genet. 2012, 22:253-255.
101. Gavin D.P., Kartan S., Chase K., Jayaraman S., Sharma R.P. Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J. Psychiatr. Res. 2009, 43:870-876.
102. Geller B., Badner J.A., Tillman R., Christian S.L., Bolhofner K., Cook E.H. Linkage disequilibrium of the brain-derived Neurotrophic factor Val66met polymorphism in children with prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 2004, 161:1698-1700.
103. Geng X., Speirs C., Lagutin O., Inbal A., Liu W., Solnica-Krezel L., Jeong Y., Epstein D.J., Oliver G. Haploinsufficiency of Six3 fails to activate sonic hedgehog expression in the ventral forebrain and causes holoprosencephaly. Dev. Cell 2008, 15:236-247.
104. Georgala P.A., Manuel M., Price D.J. The generation of superficial cortical layers is regulated by levels of the transcription factor Pax6. Cereb. Cortex 2011, 21:81-94.
105. Gershon E.S., Grennan K., Busnello J., Badner J.A., Ovsiew F., Memon S., Alliey-Rodriguez N., Cooper J., Romanos B., Liu C. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol. Psychiatry 2013, 19:890-894.
106. Gestri G., Carl M., Appolloni I., Wilson S.W., Barsacchi G., Andreazzoli M. Six3 functions in anterior neural plate specification by promoting cell proliferation and inhibiting Bmp4 expression. Development 2005, 32:2401-2413.
107. Ginns E.L., Galdzicka M., Elston R.C., Song Y.E., Paul S.M., Egeland J.A. Disruption of sonic hedgehog signaling in Ellis-van creveld dwarfism confers protection against bipolar affective disorder. Mol. Psychiatry 2014, 1-7.
108. Ginsberg S.D., Hemby S.E., Smiley J.F. Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacol. Biochem. Behav. 2012, 100:705-711.
109. Gos T., Schroeter M.L., Lessel W., Bernstein H.G., Dobrowolny H., Schiltz K., Bogerts B., Steiner J. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. J. Psychiatr. Res. 2013, 47:1694-1699.
110. Gourovitch M.L., Torrey E.F., Gold J.M., Randolph C., Weinberger D.R., Goldberg T.E. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol. Psychiatry 1999, 45:639-646.
111. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 2010, 15:1016-1022.
112. Green E.K., Rees E., Walters J.T., Smith K.G., Forty L., Grozeva D., Moran J.L., Sklar P., Ripke S., Chambert K.D., Genovese G., McCarroll S.A., Jones I., Jones L., Owen M.J., O'Donovan M.C., Craddock N., Kirov G. Copy number variation in bipolar disorder. Mol. Psychiatry 2015, (Jan 6). 10.1038/mp.2014.171.
113. Greenhill L.L., Shopsin B. Psychiatric morbidity in the offspring of patients with affective disorders. A preliminary report. Neuropsychobiology 1980, 6:159-169.
114. Greig C.L., Woodworth M.B., Galazo M.J., Padmanabhan H., Macklis J.D. Molecular logic of neocortical projection neuron specification development and diversity. Nat. Rev. Neurosci. 2013, 14:755-769.
115. Guan F., Zhang B., Yan T., Li L., Liu F., Li T., Zeng Z., Zhang B., Liu X., Li S. MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. Schizophr. Res. 2014, 152:97-104.
116. Guella I., Sequeira A., Rollins B., Morgan L., Torri F., van Erp T.G., Myers R.M., Barchas J.D., Schatzberg A.F., Watson S.J., Akil H., Bunney W.E., Potkin S.G., Macciardi F., Vawter M.P. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J. Psychiatr. Res. 2013, 47:1215-1221.
117. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007, 130:77-88.
118. Guidotti A., Pesold C., Costa E. New neurochemical markers for psychosis: a working hypothesis of their operation. Neurochem. Res. 2000, 25:1207-1218.
119. Gunde E., Novak T., Kopecek M., Schmidt M., Propper L., Stopkova P., Hoschl C., Duffy A., Alda M., Hajek T. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents; a two-center high-risk study. J. Psychol. Res. 2011, 45:76-82.
120. Guth C., Jones P., Murray R. Familial psychiatric illness and obstetric complications in early-onset affective disorder. A case-control study. Br. J. Psychiatry 1993, 163:492-498.
121. Gutiérrez B., Van Os J., Vallès V., Guillamat R., Campillo M., Fañanás L. Congenital dermatoglyphic malformations in severe bipolar disorder. Psychiatry Res. 1998, 78:133-140.
122. Hahn C., Gomez G., Restrepo D., Friedman E., Josiassen R., Pribitkin E.A., Lowry L.D., Gallop R.J., Rawson N.E. Aberrent intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am. J. Psychiatry 2005, 162:616-618.
123. Hallahan B., Newell J., Soares J.C., Brambilla P., Strakowski S.M., Fleck D.E., Kieseppä T., Altshuler L.L., Fornito A., Malhi G.S., McIntosh A.M., Yurgelun-Todd D.A., Labar K.S., Sharma V., MacQueen G.M., Murray R.M., McDonald C. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol. Psychiatry 2011, 69:326-335.
124. Hansen D.V., Lui J.H., Flandin P., Yoshikawa K., Rubenstein J.L., Alvarez-Buylla A., Kriegstein A.R. Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences. Nat. Neurosci. 2013, 16:1576-1587.
125. Haroutunian V., Katsel P., Roussos P., Davis K.L., Altshuler L.L., Bartzokis G. Myelination, oligodendrocytes, and serious mental illness. Glia 2014, 62:1856-1877.
126. Harrison P.M. The neuropathology of primary mood disorder. Brain 2002, 125:1428-1449.
127. He M., Subramanian R., Bangs F., Omelchenko T., Liem K.F., Kapoor T.M., Anderson K.V. The kinesin-4 protein Kif7 regulates mammalian hedgehog signaling by organizing the cilium tip compartment. Nat. Cell Biol. 2014, 16:663-672.
128. Hercher C., Chopra V., Beasley C.L. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J. Psychiatry Neurosci. 2014, 39:376-385.
129. Higier R.G., Jimenez A.M., Hultman C.M., Borg J., Roman C., Kizling I., Larsson H., Cannon T.D. Enhanced neurocognitive functioning and positive temperament in twins discordant for bipolar disorder. Am. J. Psychiatry 2014, 171:1191-1198.
130. Higuchi F., Uchida S., Yamagata H., Otsuki K., Hobara T., Abe N., Shibata T., Watanabe Y. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J. Psychiatr. Res. 2011, 45:1295-1300.
131. Hill M.J., Jeffries A.R., Dobson R.J.B., Price J., Bray N.J. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum. Mol. Genet. 2012, 21:1018-1024.
132. Hinna K.H., Rich K., Fex-Svenningsen Å., Benedikz E. The rat homolog of the schizophrenia susceptibility gene ZNF804A is highly expressed during brain development, particularly in growth cones. PLoS One 2015, 10.
133. Hirayasu Y., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., Yurgelun-Todd D., Zarate C., Kikinis R., Jolesz F.A., McCarley R.W. Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 1999, 156:1091-1093.
134. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., Suetsugi M., Watanabe Y. Altered gene expression of histone deacetylases in mood disorder patients. J. Psychiatr. Res. 2010, 44:263-270.
135. Holmans P., Green E.K., Pahwa J.S., Ferreira M.A., Purcell S.M., Sklar P., Wellcome Trust Case-Control Consortium, Owen M.J., O'Donovan M.C., Craddock N. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 2009, 85:13-24.
136. Horiuchi Y., Kano S., Ishizuka K., Cascella N.G., Ishii S., Talbot C.C., Jaffe A.E., Okano H., Pevsner J., Colantuoni C., Sawa A. Olfactory cells via nasal biopsy reflect the developing brain gene expression profiles: utility and limitation of the surrogate tissues in research for brain disorders. Neurosci. Res. 2013, 77:247-250.
137. Howes O.D., Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr. Psychiat. Rep. 2011, 13:493-499.
138. Hsu W.C., Nenov M.N., Shavkunov A., Panova N., Zhan M., Laezza F. Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation. PLoS One 2015, 10.
139. Hulshoff Pol H.E., van Baal G.C., Schnack H.G., Brans R.G., van der Schot A.C., Brouwer R.M., van Haren N.E., Lepage C., Collins D.L., Evans A.C., Boomsma D.I., Nolen W., Kahn R.S. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Arch. Gen. Psychiatry 2012, 69:349-359.
140. Hunsberger J.G., Fessler E.B., Chilbane F.L., Leng Y., Maric D., Elkahloun A.G., Chuang D.M. Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am. J. Transl. Res. 2013, 5:450-464.
141. Hussain T., Mulherkar R. Lymphoblastoid cell lines: a continuous in vitro source of cells to study carcinogen sensitivity and DNA repair. Int. J. Mol. Cell Med. 2012, 1:75-87.
142. Iaconelli J., Huang J.H., Berkovitch S.S., Chattopadhyay S., Mazitschek R., Schreiber S.L., Haggarty S.J., Karmacharya R. HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells. ACS Chem. Biol. 2015, 10:883-890.
143. Iavarone F., Melis M., Platania G., Cabras T., Manconi B., Petruzzelli R., Cordaro M., Siracusano A., Faa G., Messana I., Zanasi M., Castagnola M. Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics. J. Proteome 2014, 103:15-22.
144. Iwamoto K., Bundo M., Ueda J., Oldman M.C., Ukai W., Hashitoto E., Saita T., Geschwind D.H., Kata T. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011, 21:688-696.
145. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., Kato T. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 2005, 25:5376-5381.
146. Jerrell J.M., McIntyre R.S., Park Y.M. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 2014, 75:e1278-e1283.
147. Juselius S., Kieseppä T., Kaprio J., Lönnqvist J., Tuulio-Henriksson A. Executive functioning in twins with bipolar I disorder and healthy co-twins. Arch. Clin. Neuropsychol. 2009, 24:599-606.
148. Kaminsky Z., Jones I., Verma R., Saleh L., Trivedi H., Guintivano J., Akman R., Zandi P., Lee R.S., Potash J.B. DNA methylation and expression of KCNQ3 in bipolar disorder. Bipolar Disord. 2015, 17:150-159.
149. Kato T., Iwayama Y., Kakiuchi C., Iwamoto K., Yamada K., Minable Y., Nakamura K., Mori N., Fujii K., Nanko S., Yoshikawa T. Geneexpression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol. Psychiatry 2005, 10:1045-1055.
150. Kato T., Iwamoto K. Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology 2014, 80:133-139.
151. Kay G., Sargeant M., McGuffin P., Whatley S., Marchbanks R., Bullock T., Montgomery S., Elliott J.M. The lymphoblast beta-adrenergic receptor in bipolar depressed patients: effect of chronic incubation with lithium chloride. J. Affect. Disord. 1994, 30:185-192.
152. Kazuno A.A., Ohtawa K., Otsuki K., Usui M., Sugawara H., Okazaki Y., Kato T. Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study. PLoS One 2013, 8.
153. Kelley R., Chang K.D., Garrett A., Alegría D., Thompson P., Howe M., Reiss A.L. Deformations of amygdala morphology in familial pediatric bipolar disorder. Bipolar Disord. 2013, 15:795-802.
154. Kempton M.J., Geddes J.R., Ettinger U., Williams S.C., Grasby P.M. Meta-analysis, database and meta-regression of 98 structural imaging studies in bipolar disorder. Arch. Gen. Psychiatry 2008, 65:1017-1032.
155. Kempton M.J., Haldane M., Jogia J., Grasby P.M., Collier D., Frangou S. Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. J. Neurosci. 2009, 29:10863-10868.
156. Kent L., Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder?. J. Affect. Disord. 2003, 73:211-221.
157. Kieseppä T., van Erp T.G., Haukka J., Partonen T., Cannon T.D., Poutanen V.P., Kaprio J., Lönnqvist J. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol. Psychiatry 2003, 54:896-905.
158. Kim A.H., Reimers M., Maher B., Williamson V., McMichael O., McClay J.L., van den Oord E.J., Riley B.P., Kendler K.S., Vladimirov V.I. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124:183-191.
159. Kim E.J., Battiste J., Nakagawa Y., Johnson J.E. Ascl1 (Mash1) lineage cells contribute to discrete cell populations in CNS architecture. Mol. Cell. Neurosci. 2008, 38:595-606.
160. Kim E.Y., Miklowitz D.J. Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disord. 2002, 4:215-225.
161. Kim S., Webster M.J. The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010, 35:473-482.
162. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 2010, 15:326-336.
163. Kim S., Webster M.J. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 2011, 16:452-461.
164. Kinney D.K., Yurgelun-Todd D.A., Levy D.L., Medoff D., Lajonchere C.M., Radford-Paregol M. Obstetrical complications in patients with bipolar disorder and their siblings. Psychiatry Res. 1993, 48:47-56.
165. Kinney D.K., Yurgelun-Todd D.A., Tohen M., Tramer S. Pre- and perinatal complications and risk for bipolar disorder: a retrospective study. J. Affect. Disord. 1998, 50:117-124.
166. Konopaske G.T., Lange N., Coyle J.T., Benes F.M. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014, 71:1323-1331.
167. Kordelli E., Lambert S., Bennett V.J., Ankyrin G. A new ankyrin gene with neural-specific isoforms localized at the axon initial segment and node of Ranvier. J. Biol. Chem. 1995, 270:2352-2359.
168. Kramer A.F., Erickson K.I. Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn. Sci. 2007, 11:342-348.
169. Krey J.F., Pasca S.P., Scheglovitov A., Yazawa M., Schwemberger R., Rasmusson R., Dolmetsch R.E. Timothy syndrome is associated with activity-dependent dendritic retraction in human and rodent neurons. Nat. Neurosci. 2013, 16:201-209.
170. Kroll T.T., O'Leary D.D. Ventralized dorsal telencephalic progenitors in Pax6 mutant mice generate GABA interneurons of a lateral ganglionic eminence fate. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7374-7379.
171. Kwon E., Wang W., Tsai L.H. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol. Psychiatry 2013, 18:11-12.
172. Labonté B., Suderman M., Maussion G., Navaro L., Yerko V., Mahar I., Bureau A., Mechawar N., Szyf M., Meaney M.J., Turecki G. Genome-wide epigenetic regulation by early-life trauma. Arch. Gen. Psychiatry 2012, 69:722-731.
173. Ladd-Acosta C., Pevsner J., Sabunciyan S., Yolken R.H., Webster M.J., Dinkins T., Callinan P.A., Fan J.-B., Potash J.B., Feinberg A.P. DNA methylation signatures in the human brain. Am. J. Hum. Genet. 2007, 81:1304-1315.
174. Laeng P., Pitts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H., Thyagarajan R., Mallon B.S., Altar C.A. The mood stabilizer Valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J. Neurochem. 2004, 91:238-251.
175. Lancaster M.A., Renner M., Martin C.A., Wenzel D., Bicknell L.S., Hurles M.E., Homfray T., Penninger J.M., Jackson A.P., Knoblich J.A. Cerebral organoids model human brain development and microcephaly. Nature 2013, 501:373-379.
176. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foà R., Schliwka J., Fuchs U., Novosel A., Müller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
177. Lee S.A., Tsao T.T.H., Yang K.C., Lin H., Kuo Y.L., Hsu C.H., Lee W.K., Huang K.C., Kao C.Y. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinf. 2011, 12:S13. (S20). 10.1186/1471-2105-12-S13-S20.
178. Lee Y., Mattai A., Long R., Rapoport J.L., Gogtay N., Addington A.M. Microduplications disrupting the MYT1L gene (2p25.3) are asssociated with schizophrenia. Psychiatr. Genet. 2012, 22:206-209.
179. Le-Niculescu H., Patel S.D., Bhat M., Kuczenski R., Faraone S.V., Tsuang M.T., McMahon F.J., Schork N.J., Nurnberger J.I., Niculescu A.B. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:155-181.
180. Li, M., Luo, X.J., Landen, M., Bergen, S.E., Hultman, C.M., Li, X., Zang, W., Yao, Y.G., Zhang, C., Liu, J., Mattheisen, M., Cichon, S., Muhleisen, T.W., Degenhardt, F.A., Nothen, M.M., Schulze, T.G., Grigoroiu-Serbanescu, M., Li, H., Fuller, C.K., Chen, C., Dong, Q., Chen, C., Jamain, S., Leboyer, M., Bellivier, F., Etain, B., Kahn, J.P., Henry, C., Preisig, M., Kutalik, Z., Castelao, E., Wright, A., Mitchell, P.B., Fullerton, J.M., Schofield, P.R., Montgomery, G.W., Medland, S.E., Gordon, S.D., Martin, N.G., MooDS Consortium, Swedish Bipolar Study Group, Rietschel, M., Liu, C., Kleinman, J.E., Hyde, T.M., Weinberger, D.R., Su, B., 2015. Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, Hippocampal structure and cognitive performance. Br. J. Psychiatry, (pii: bbjp.bp.114.156976).
181. Li M., Luo X.J., Rietschel M., Lewis C.M., Mattheisen M., Müller-Myhsok B., Jamain S., Leboyer M., Landén M., Thompson P.M., Cichon S., Nöthen M.M., Schulze T.G., Sullivan P.F., Bergen S.E., Donohoe G., Morris D.W., Hargreaves A., Gill M., Corvin A., Hultman C., Toga A.W., Shi L., Lin Q., Shi H., Gan L., Meyer-Lindenberg A., Czamara D., Henry C., Etain B., Bis J.C., Ikram M.A., Fornage M., Debette S., Launer L.J., Seshadri S., Erk S., Walter H., Heinz A., Bellivier F., Stein J.L., Medland S.E., Arias Vasquez A., Hibar D.P., Franke B., Martin N.G., Wright M.J., Consortium M.D.S.B., Group S.B.S., Initiative A.''s.D.N., ENIGMA Consortium, CHARGE Consortium, Su B. Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, Hippocampal structure and function, and bipolar disorder susceptibility. Mol. Psychiatry 2014, 19:452-461.
182. Li X.J., Zhang X., Johnson M.A., Wang Z.B., Lavavute T., Zhang S.C. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009, 136:4055-4063.
183. Li Y., Camarillo C., Xu J., Arana T.B., Xiao Y., Zhao Z., Chen H., Ramirez M., Zavala J., Escamilla M.A., Armas R., Mendoza R., Ontiveros A., Nicolini H., Magana A.A., Rubin L.P., Li X., Xu C. Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder. Biomed. Res. Int. 2015, 10.1155/2015/201587.
184. Lin C.Y., Sawa A., Jaaro-Peled H. Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol. Dis. 2012, 45:48-56.
185. Lin M., Hrabovsky A., Pedrosa E., Wang T., Zheng D., Lachman H.M. Allele-biased expression in differentiating human neurons: implications for neuropsychiatric disorders. PLoS One 2012, 7.
186. Lin M., Pedrosa E., Shah A., Hrabovsky A., Magbool S., Zheng D., Lachman H.M. RNA-seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One 2011, 6.
187. Lin M., Zhao D., Hrabovsky A., Pedrosa E., Zheng D., Lachman H.M. Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human Telencephalon. PLoS One 2014, 9.
188. Liodis P., Denaxa M., Grigoriou M., Akufo-Addo C., Yanagawa Y., Pachnis V. Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J. Neurosci. 2007, 27:3078-3089.
189. Lister R., Mukamel E.A., Nery J.R., Urich M., Puddifoot C.A., Johnson N.D., Lucero J., Huang Y., Dwork A.J., Schultz M.D., Yu M., Tonti-Filippini J., Heyn H., Hu S., Wu J.C., Rao A., Esteller M., He C., Haghighi F.G., Sejnowski T.J., Behrens M.M., Ecker J.R. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905. 10.1126/science.1237905.
190. Liu Y., Blackwood D.H., Caesar S., de Geus E.J., Farmer A., Ferreira M.A., Ferrier I.N., Fraser C., Gordon-Smith K., Green E.K., Grozeva D., Gurling H.M., Hamshere M.L., Heutink P., Holmans P.A., Hoogendijk W.J., Hottenga J.J., Jones L., Jones I.R., Kirov G., Lin D., McGuffin P., Moskvina V., Nolen W.A., Perlis R.H., Posthuma D., Scolnick E.M., Smit A.B., Smit J.H., Smoller J.W., St.Clair D., van Dyck R., Verhage M., Willemsen G., Young A.H., Zandbelt T., Boomsma D.I., Craddock N., O'Donovan M.C., Owen M.J., Penninx B.W., Purcell S., Sklar P., Sullivan P.F., Consortium W.T.C.-C. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol. Psychiatry 2011, 16:2-4.
191. Logotheti M., Papadodima O., Venizelos N., Chatziioannou A., Kolisis F. A comparative genomic study in schizophrenia and in bipolar disorder patients, based on microarray expression profiling meta-analysis. Sci. World J. 2013, http://doi.org/10.1155/20113/685917.
192. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
193. Lubbers B.R., Smit A.B., Spijker S., van den Oever M.C. Neural ECM in addiction, schizophrenia, and mood disorder. Prog. Brain Res. 2014, 214:263-284.
194. Lyoo I.K., Dager S.R., Kim J.E., Yoon S.J., Friedman S.D., Dunner D.L., Renshaw P.F. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010, 5:1743-1750.
195. Machado-Vieira R., Soeiro-De-Souza M.G., Richards E.M., Teixeira A.L., Zarate C.A. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J. Biol. Psychiatry 2014, 15:84-95.
196. MacMaster F.P., Langevin L.M., Jaworska N., Kemp A., Sembo M. Corpus callosal morphology in youth with bipolar depression. Bipolar Disord. 2014, 16:889-893.
197. Madison J.M., Zhou F., Nigam A., Hussain A., Barker D.D., Nehme R., van der Ven K., Hsu J., Wolf P., Fleishman M., O'Dushlaine C., Rose S., Chambert K., Lau F.H., Ahfeldt T., Rueckert E.H., Sheridan S.D., Fass D.M., Nemesh J., Mullen T.E., Daheron L., McCarroll S., Sklar P., Perlis R.H., Haggarty S.J. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. Mol. Psychiatry 2015, 20:703-717.
198. Mahon K., Burdick K.E., Szeszko P.R. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci. Biobehav. Rev. 2010, 34:533-554.
199. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
200. Mariani J., Coppola G., Zhang P., Abyzov A., Provini L., Tomasini L., Amenduni M., Szekely A., Palejev D., Wilson M., Gerstein M., Grigorenko E.L., Chawarska K., Pelphrey K.A., Howe J.R., Vaccarino F.M. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 2015, 162:375-390.
201. Marin O. Cellular and molecular mechanisms controlling the migration of neocortical interneurons. Eur. J. Neurosci. 2013, 38:2019-2029.
202. Marin O., Anderson S.A., Rubenstein J.L. Origin and molecular specification of Striatal interneurons. J. Neurosci. 2000, 20:6063-6078.
203. Maroof A.S., Keros S., Tyson J.A., Ying S.W., Ganat Y.M., Merkle F.T., Liu B., Goulburn A., Stanley E.G., Elefanty A.G., Widmer H.R., Eggan K., Goldstein P.A., Anderson S.A., Studer L. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013, 12:559-572.
204. Masi G., Mucci M., Pfanner C., Berloffa S., Magazu A., Perugi G. Developmental pathways for different subtypes of early-onset bipolarity in youths. J. Child Psychiatry 2012, 73:1335-1341.
205. Masters J.R.W. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 2000, 1:233-236.
206. Matigian N., Windus L., Smith H., Filippich C., Pantelis C., McGrath J., Mowry B., Hayward N. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol. Psychiatry 2007, 12:815-825.
207. Matsuo K., Kopecek M., Nicoletti M.A., Hatch J.P., Watanabe Y., Nery F.G., Zunta-Soares G., Soares J.C. New structural brain imaging endophenotype in bipolar disorder. Mol. Psychiatry 2012, 17:412-420.
208. Matsuo K., Sanches M., Brambilla P., Soares J.C. Structural Brain Abnormalities in Bipolar Disorder. The Bipolar Brain, Integrating Neuroimaging and Genetics 2012, 17-51. Oxford University Press, New York. S.M. Strakowski (Ed.).
209. McCurdy R.D., Féron F., Perry C., Chant D.C., McLean D., Matigian N., Hayward N.K., McGrath J.J., Mackay-Sim A. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr. Res. 2006, 82:163-173.
210. McDonald C., Bullmore E., Sham P., Chitnis X., Suckling J., MacCabe J., Walshe M., Murray R.M. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br. J. Psychiatry 2005, 186:369-377.
211. McDonald C., Zanelli J., Rabe-Hesketh S., Ellison-Wright I., Sham P., Kalidindi S., Murray R.M., Kennedy N. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol. Psychiatry 2004, 56:411-417.
212. McEachin R.C., Chen H., Sartor M.A., Saccone S.F., Keller B.J., Prossin A.R., Cavalcoli J.D., McInnis M.G. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder. BMC Syst. Biol. 2010, 4:158.
213. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 2003, 60:497-502.
214. McIntosh A.M., Job D.E., Moorhead T.W., Harrison L.K., Forrester K., Lawrie S.M., Johnstone E.C. Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol. Psychiatry 2004, 56:544-552.
215. McNamara R.K., Nandagopal J.J., Strakowski S.M., DelBello M.P. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 2010, 24:983-996.
216. Medina L., Abellan A. Development and evolution of the pallium. Sem. Cell Dev. Biol. 2009, 20:698-711.
217. Mehler M.F., Gokhan S. Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog. Neurobiol. 2001, 63:337-363.
218. Menezes P.R., Rasmussen L.G., Zammit S., Sipos A., Garrison G.L., Tynelius P., Gunnell D. Paternal and maternal ages at conception and risk of bipolar affective disorder in their offspring. Psychol. Med. 2010, 40:477-485.
219. Mertens J., Wang Q.W., Kim Y., Yu D.X., Pharm S., Yang B., Zheng Y., Diffenderer K.E., Zhang J., Soltani S., Eames T., Schafer S.T., Boyer L., Marchetto M.C., Nurnberger J.I., Calabrese J.R., Odegaard K.J., McCarthy M.J., Zandi P.P., Alba M., Nievergelt C.M., The Pharmacogenetics of Bipolar Disorder Study, Mi S., Brennand K.J., Kelsoe J.R., Gage F.H., Yao J. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 2015, 527:95-99. 10.1038/nature15526.
220. Meza-Sosa K.F., Pedraza-Alva G., Perez-Martinez L. MicroRNAs: key triggers of neuronal cell fate. Front. Cell. Neurosci. 2014, 8:175.
221. Mill J., Tang T., Kaminsky Z., Khare T., Yazdanpanah S., Bouchard L., Jia P., Assadzadeh A., Flanagan J., Schumacher A., Wang S.-C., Petronis A. Epigenetic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 2008, 82:696-711.
222. Miller J.A., Ding S.L., Sunkin S.M., Smith K.A., Ng L., Szafer A., Ebbert A., Riley Z.L., Royall J.J., Aiona K., Arnold J.M., Bennet C., Bertagnolli D., Brouner K., Butler S., Caldejon S., Carey A., Cuhaciyan C., Dalley R.A., Dee N., Dolbeare T.A., Facer B.A., Feng D., Fliss T.P., Gee G., Goldy J., Gourley L., Gregor B.W., Gu G., Howard R.E., Jochim J.M., Kuan C.L., Lau C., Lee C.K., Lee F., Lemon T.A., Lesnar P., McMurray B., Mastan N., Mosqueda N., Naluai-Cecchini T., Ngo N.K., Nyhus J., Oldre A., Olson E., Parente J., Parker P.D., Parry S.E., Stevens A., Pletikos M., Reding M., Roll K., Sandman D., Sarreal M., Shapouri S., Shapovalova N.V., Shen E.H., Sjoquist N., Slaughterbeck C.R., Smith M., Sodt A.J., Williams D., Zöllei L., Fischl B., Gerstein M.B., Geschwind D.H., Glass I.A., Hawrylycz M.J., Hevner R.F., Huang H., Jones A.R., Knowles J.A., Levitt P., Phillips J.W., Sestan N., Wohnoutka P., Dang C., Bernard A., Hohmann J.G., Lein E.S. Transcriptional landscape of the prenatal human brain. Nature 2014, 508:199-206.
223. Ming G.L., Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011, 70:687-702.
224. Monkul E.S., Matsuo K., Nicoletti M.A., Dierschke N., Hatch J.P., Dalwani M., Brambila P., Caetano S., Sassi R.B., Mallinger A.G., Soares J.C. Frontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci. Lett. 2007, 429:7-11.
225. Moore G.J., Cortese B.M., Glitz D.A., Zajac-Benitez C., Quiroz J.A., Uhde T.W., Drevets W.C., Manji H.K. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J. Clin. Psychiatry 2009, 70:699-705.
226. Moreau M.P., Bruse S.E., David-Rus R.D., Buyske S., Brzustowicz L.M. Altered microRNA expression profiles from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 2011, 69:188-193.
227. Muller D.J., de Luca V., Sicard T., King N., Strauss J., Kennedy J.L. Brain-derived Neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br. J. Psychiatry 2006, 189:317-323.
228. Munoz-Estrada J., Benitez-King G., Berlanga C., Meza I. Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment. CNS Neurosci. Ther. 2015, 21:446-453.
229. Muzio L., Di Benedetto B., Stoykova A., Boncinelli E., Gruss P., Mallamaci A. Conversion of cerebral cortex into basal ganglia in Emx2 (-/-) Pax6(Sey/Sey) double mutant mice. Nat. Neurosci. 2002, 5:737-745.
230. Najit P., Wang F., Spencer L., Johnston J.A.Y., Cox Lippard E.T., Pittman B.P., Lacadie C., Staib L.H., Papademetris X., Blumberg H.P. Anterior cortical development during adolescence in bipolar disorder. Biol. Psychiatry 2015, 10.1016/biopsych.2015.03.026.
231. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 2007, 62:773-783.
232. Narayan S., McLean C., Sawa A., Lin S.Y., Rai N., Hipolito M.S., Cascella N., Nurenberger J.J., Ishizuka K., Nwulia E.A. Olfactory neurons obtained through nasal biopsy combined with laser-capture microdissection: a potential approach to study treatment response in mental disorders. J. Vis. Exp. 2014, 4. 10.3791/51853.
233. Nasrallah H.A. Neurodevelopmental aspects of bipolar affective disorder. Biol. Psychiatry 1991, 29:1-2.
234. Neale B.M., Sklar P. Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. Curr. Opin. Neurobiol. 2015, 30:131-138.
235. Ng W.X., Lau I.Y., Graham S., Sim K. Neurobiological evidence for thalamic, Hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci. Biobehav. Rev. 2009, 33:336-354.
236. Nicholas C.R., Chen J., Tang Y., Southwell D.G., Chalmers N., Vogt D., Arnold C.M., Chen Y.J., Stanley E.G., Elefanty A.G., Sasai Y., Alvarez-Buylla A., Rubensteein J.L.R., Kriegstein A.R. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 2013, 12:573-586.
237. Nóbrega-Pereira S., Marín O. Transcriptional control of neuronal migration in the developing mouse brain. Cereb. Cortex 2009, 19(S1):107-113.
238. Noga J.T., Vladar K., Torrey E.F. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res. 2001, 106:25-34.
239. Nord A.S., Pattabiraman K., Visel A., Rubenstein J.L.R. Genomic perspectives of transcriptional regulation in forebrain development. Neuron 2015, 85:27-47.
240. Numata S., Ye T., Hyde T.M., Guitart-Navarro X., Tao R., Wininger M., Colantuoni C., Weinberger D.R., Kleinman J.E., Lipska B.K. DNA methylation signatures in development and aging of the human prefrontal cortex. Am. J. Hum. Genet. 2012, 90:260-272.
241. Nurnberger J.I., Koller D.L., Jung J., Edenberg H.J., Foroud T., Guella I., Vawter M.P., Kelsoe J.R., the Psychiatric Genomics Consortium Bipolar Group Identification of pathways for bipolar disorder. A meta-analysis. JAMA Psychiatry 2015, 71:657-664.
242. Nurnberger J.I., McInnis M., Reich W., Kastelic E., Wilcox H.C., Glowinski A., Mitchell P., Fisher C., Erpe M., Gershon E.S., Berrettini W., Laite G., Schweitzer R., Rhoadarmer K., Coleman V.V., Cai X., Azzouz F., Liu H., Kamali M., Brucksch C., Monahan P.O. A high-risk study of bipolar disorder. Childhood clinical phenotypes as precursors of major mood disorders. Arch. Gen. Psychiatry 2011, 68:1012-1020.
243. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., International Schizophrenia Consortium, Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry 2011, 16:286-292.
244. O'Dushlaine C., the Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 2015, 1:199-209.
245. Okerlund N.D., Cheyette B.N. Synaptic Wnt signaling-a contributor to major psychiatric disorders?. J. Neurodev. Disord. 2011, 3:162-174.
246. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13290-13295.
247. O'Shea K.S., McInnis M.G. Induced pluripotent stem cell (iPSC) models of bipolar disorder. Neuropsychopharmacology 2015, 40:248-249.
248. Ovadia G., Shifman S. The genetic variation of RELN expression in schizophrenia and bipolar disorder. PLoS One 2011, 6.
249. Pandey G.N., Rizavi H.S., Tripathi M., Ren X. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2015, 17:160-171.
250. Pandya C.D., Howell K.R., Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2012, 46:214-223.
251. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., Cord B., Palmeer T.D., Chikahisa S., Nishino S., Bernstein J.A., Hallmayer J., Geschwind D.H., Dolmetsch R.E. Using iPSC-derived neurons to uncover cellular phenotypes associated with timothy syndrome. Nat. Med. 2011, 17:1657-1662.
252. Pavuluri M.N., Henry D.B., Nadimpalli S.S., O'Connor M.M., Sweeney J.A. Biological risk factors in pediatric bipolar disorder. Biol. Psychiatry 2006, 60:639-641.
253. Pedroso I., Lourdusamy A., Rietschel M., Nothen M.M., Cichon S., McGuffin P., Al-Chalabi A., Barnes M.R., Breen G. Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes. Biol. Psychiatry 2012, 72:311-317.
254. Perich T., Lau P., Hadzi-Pavlovic D., Roberts G., Franklanad A., Wright A., Green M., Breakspear M., Corry J., Radlinska B., McCormack C., Joslyn C., Levy F., Lenroot R., Nurnberger J.I., Mitchell P.B. What clinical features precede the onset of bipolar disorder?. J. Psychiatry Res. 2015, 62:71-77.
255. Perlis R.H., Dennehy E.B., Miklowitz D.J., Del Bello M.P., Ostacher M., Calabrese J.R., Ametrano R.M., Wisniewski S.R., Bowden C.L., Thase M.E., Nierenberg A.A., Sachs G. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from STEP-BD study. Bipolar Disord. 2009, 11:391-400.
256. Petronis A. Epigenetics and bipolar disorder: new opportunities and challenges. Am. J. Med. Genet. C: Semin. Med. Genet. 2003, 123C:65-75.
257. Pinto C., Souza R.P., Lioult D., Semeralul M., Kennedy J.L., Warsh J.J., Wong A.H., Luca V.D. Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:533-538.
258. Poliak S., Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 2003, 4:968-980.
259. Pollock K., Stroemer P., Patel S., Stevanato L., Hope A., Miljan E., Dong Z., Hodges H., Price J., Sinden J.D. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol. 2006, 199:143-155.
260. Putoux A., Thomas S., Coene K.L., Davis E.E., Alanay Y., Ogur G., Uz E., Buzas D., Gomes C., Patrier S., Bennett C.L., Elkhartoufi N., Frison M.H., Rigonnot L., Joyé N., Pruvost S., Utine G.E., Boduroglu K., Nitschke P., Fertitta L., Thauvin-Robinet C., Munnich A., Cormier-Daire V., Hennekam R., Colin E., Akarsu N.A., Bole-Feysot C., Cagnard N., Schmitt A., Goudin N., Lyonnet S., Encha-Razavi F., Siffroi J.P., Winey M., Katsanis N., Gonzales M., Vekemans M., Beales P.L., Attié-Bitach T. KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes. Nat. Genet. 2011, 43:601-606.
261. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 2001, 49:741-752.
262. Reichenberg A., Rabinowitz J., Weiser M., Mark M., Kaplan Z., Davidson M. Premorbid functioning in a national population of male twins discordant for psychoses. Am. J. Psychiatry 2000, 157:1514-1516.
263. Rej S., Butters M.A., Aizenstein H.J., Begley A., Tsay J., Reynolds C.F., Mulsant B.H., Gildengers A. Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age. Int. J. Geriatr. Psychiatry 2014, 29:421-427.
264. Rheinbay E., Suva M.L., Gillespie S.M., Wakimoto H., Patel A.P., Shahid M., Oksuz O., Rabkin S.D., Martuza R.L., Rivera M.N., Louis D.N., Kasif S., Chi A.S., Bernstein B.E. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell. Rep. 2013, 3:1567-1579.
265. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D., Kendler K.S. Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample. Mol. Psychiatry 2010, 15:29-37.
266. Roadmap Epigenomics Consortium, Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., Kheradpour P., Zhang Z., Wang J., Ziller M.J., Amin V., Whitaker J.W., Schultz M.D., Ward L.D., Sarkar A., Quon G., Sandstrom R.S., Eaton M.L., Wu Y.C., Pfenning A., Wang X., Claussnitzer M., Liu Y., Coarfa C., Harris R.A., Shoresh N., Epstein C.B., Gjoneska E., Leung D., Xie W., Hawkins R.D., Lister R., Hong C., Gascard P., Mungall A.J., Moore R., Chuah E., Tam A., Canfield T.K., Hansen R.S., Kaul R., Sabo P.J., Bansal M.S., Carles A., Dixon J.R., Farh K.H., Feizi S., Karlic R., Kim A.R., Kulkarni A., Li D., Lowdon R., Elliott G., Mercer T.R., Neph S.J., Onuchic V., Polak P., Rajagopal N., Ray P., Sallari R.C., Siebenthall K.T., Sinnott-Armstrong N.A., Stevens M., Thurman R.E., Wu J., Zhang B., Zhou X., Abdennur N., Adli M., Akerman M., Barrera L., Antosiewicz-Bourget J., Ballinger T., Barnes M.J., Bates D., Bell R.J., Bennett D.A., Bianco K., Bock C., Boyle P., Brinchmann J., Caballero-Campo P., Camahort R., Carrasco-Alfonso M.J., Charnecki T., Chen H., Chen Z., Cheng J.B., Cho S., Chu A., Chung W.Y., Cowan C., Athena, Deng Q., Deshpande V., Diegel M., Ding B., Durham T., Echipare L., Edsall L., Flowers D., Genbacev-Krtolica O., Gifford C., Gillespie S., Giste E., Glass I.A., Gnirke A., Gormley M., Gu H., Gu J., Hafler D.A., Hangauer M.J., Hariharan M., Hatan M., Haugen E., He Y., Heimfeld S., Herlofsen S., Hou Z., Humbert R., Issner R., Jackson A.R., Jia H., Jiang P., Johnson A.K., Kadlecek T., Kamoh B., Kapidzic M., Kent J., Kim A., Kleinewietfeld M., Klugman S., Krishnan J., Kuan S., Kutyavin T., Lee A.Y., Lee K., Li J., Li N., Li Y., Ligon K.L., Lin S., Lin Y., Liu J., Liu Y., Luckey C.J., Ma Y.P., Maire C., Marson A., Mattick J.S., Mayo M., McMaster M., Metsky H., Mikkelsen T., Miller D., Miri M., Mukamel E., Nagarajan R.P., Neri F., Nery J., Nguyen T., O'Geen H., Paithankar S., Papayannopoulou T., Pelizzola M., Plettner P., Propson N.E., Raghuraman S., Raney B.J., Raubitschek A., Reynolds A.P., Richards H., Riehle K., Rinaudo P., Robinson J.F., Rockweiler N.B., Rosen E., Rynes E., Schein J., Sears R., Sejnowski T., Shafer A., Shen L., Shoemaker R., Sigaroudinia M., Slukvin I., Stehling-Sun S., Stewart R., Subramanian S.L., Suknuntha K., Swanson S., Tian S., Tilden H., Tsai L., Urich M., Vaughn I., Vierstra J., Vong S., Wagner U., Wang H., Wang T., Wang Y., Weiss A., Whitton H., Wildberg A., Witt H., Won K.J., Xie M., Xing X., Xu I., Xuan Z., Ye Z., Yen C.A., Yu P., Zhang X., Zhang X., Zhao J., Zhou Y., Zhu J., Zhu Y., Ziegler S., Beaudet A.E., Boyer L.A., De Jager P.L., Farnham P.J., Fisher S.J., Haussler D., Jones S.J., Li W., Marra M.A., McManus M.T., Sunyaev S., Thomson J.A., Tlsty T.D., Tsai L.H., Wang W., Waterland R.A., Zhang M.Q., Chadwick L.H., Bernstein B.E., Costello J.F., Ecker J.R., Hirst M., Meissner A., Milosavljevic A., Ren B., Stamatoyannopoulos J.A., Wang T., Kellis M., Bernstein B.E., Costello J.F., Ecker J.R., Hirst M., Meissner A., Milosavljevic A., Ren B., Stamatoyannopoulos J.A., Wang T., Kellis M. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518:317-330.
267. Robinson L.J., Thompson J.M., Gallagher P., Goswami U., Young A.H., Ferrier I.N., Moore P.B. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J. Affect. Disord. 2006, 93:105-115.
268. Rohr K.B., Barth K.A., Varga Z.M., Wilson S.W. The nodal pathway acts upstream of hedgehog signaling to specify ventral telencephalic identity. Neuron 2001, 29:341-351.
269. Rosso I.M., Killgore W.D., Cintron C.M., Gruber S.A., Tohen M., Yurgelun-Todd D.A. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol. Psychiatry 2007, 61:743-749.
270. Roybal D.J., Barnea-Goraly N., Kelley R., Bararpour L., Howe M.E., Reiss A.L., Chang K.D. Widespread white matter tract aberrations in youth with familial risk for bipolar disorder. Psychiatry Res. 2015, 232:184-192.
271. Rueckert E.H., Barker D., Ruerfer D., Beergen S.E., O'Dushlaine C., Luce C.J., Sheridan S.D., Theriault K.M., Chambert K., Moran J., Purcell S., J.M., Haggarty S.J., Sklar P. Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder. Mol. Psychiatry 2013, 18. 10.1038/mp.2012.104.
272. Ruzicka W.B., Subburaju S., Benes F.M. Circuit- and diagnosis-specific DNA methylation changes at γ-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder. JAMA Psychiatry 2015, 72:541-551.
273. Ryu E.J., Wang J.Y., Le N., Baloh R.H., Gustin J.A., Schmidt R.E., Milbrandt J. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J. Neurosci. 2007, 27:11552-11559.
274. Sanches M., Keshavan M.S., Brambilla P., Soares J.C. Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32:1617-1627.
275. Sanchez-Gistau V., Baeza I., Arango C., Gonzalez-Pinto A., de la Serna E., Parellada M., Graell M., Paya B., Llorente C., Castro-Fornieles J. The affective dimension of early-onset psychosis and its relationship with suicide. J. Child Psychol. Psychiatry 2015, 56:747-755.
276. Sassi R.B., Nicoletti M., Brambilla P., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci. Lett. 2002, 329:243-245.
277. Scanlon C., Anderson-Schmidt H., Kilmartin L., McInerney S., Kenney J., McFarland J., Waldron M., Ambati S., Fullard A., Logan S., Hallahan B., Barker G.J., Elliott M.A., McCarthy P., Cannon D.M., McDonald C. Cortical thinning and caudate abnormalities in first episode psychosis and their association with clinical outcome. Schizophr. Res. 2014, 159:36-42.
278. Schloesser R.J., Chen G., Manji H.K. Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder. Int. Rev. Neurobiol. 2007, 77:143-178.
279. Schmitt A., Malchow B., Hasan A., Falkai P. The impact of environmental factors in severe psychiatric disorders. Front. Neurosci. 2014, 8:19.
280. Schulze T.G., Detera-Wadleigh S.D., Akula N., Gupta A., Kassem L., Steele J., Pearl J., Strohmaier J., Breuer R., Schwartz M., Propping P., Nothen M.M., Cichon S., Schumacher J. Two variants in ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol. Psychiatry 2009, 14:487-491.
281. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., Ekholm J., Cichon S., Turecki G., Claes S., Kelsoe J.R., Schofield P.R., Badenhop R.F., Morissette J., Coon H., Blackwood D., McInnes L.A., Foroud T., Edenberg H.J., Reich T., Rice J.P., Goate A., McInnis M.G., McMahon F.J., Badner J.A., Goldin L.R., Bennett P., Willour V.L., Zandi P.P., Liu J., Gilliam C., Juo S.H., Berrettini W.H., Yoshikawa T., Peltonen L., Lönnqvist J., Nöthen M.M., Schumacher J., Windemuth C., Rietschel M., Propping P., Maier W., Alda M., Grof P., Rouleau G.A., Del-Favero J., van Broeckhoven C., Mendlewicz J., Adolfsson R., Spence M.A., Luebbert H., Adams L.J., Donald J.A., Mitchell P.B., Barden N., Shink E., Byerley W., Muir W., Visscher P.M., Macgregor S., Gurling H., Kalsi G., McQuillin A., Escamilla M.A., Reus V.I., Leon P., Freimer N.B., Ewald H., Kruse T.A., Mors O., Radhakrishna U., Blouin J.L., Antonarakis S.E., Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am. J. Hum. Genet. 2003, 73:49-62.
282. Selemon L., Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr. Mol. Med. 2003, 3:427-436.
283. Selvaraj S., Arnone D., Job D., Stanfield A., Farrow T.F., Nugent A.C., Scherk H., Gruber O., Chen X., Sachdev P.S., Dickstein D.P., Malhi G.S., Ha T.H., Ha K., Phillips M.L., McIntosh A.M. Grey matter differences in bipolar disorder: a meta-anallysis of voxel-based morphometry studies. Bipolar Disord. 2012, 14:135-145.
284. Serafini G., Pompili M., Borgwardt S., Houenou J., Geoffroy P.A., Jardri R., Girardi P., Amore M. Brain changes in early-onset bipolar and unipolar depressive disorders: a systematic review in children and adolescents. Eur. Child Adolesc. Psychiatry 2014, 23:1023-1041.
285. Sequeira A., Turecki J.G. Genome wide expression studies in mood disorders. OMICS 2006, 10:444-454.
286. Sharma R.P., Rosen C., Kartan S., Guidotti A., Costa E., Grayson D.R.R., Chase K. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr. Res. 2006, 88:227-231.
287. Shulha H.P., Cheung I., Guo Y., Akbarian S., Weng Z. Coordinated cell-type specific epigenetic remodeling in prefrontal cortex begins before birth and continues into early adulthood. PLoS Genet. 2013, 9.
288. Sie L., Loong S., Tan E.K. Utility of lymphoblastoid cell lines. J. Neurosci. Res. 2009, 87:1953-1959.
289. Sigurdsson E., Fombonne E., Sayal K., Checkley S. Neurodevelopmental antecedents of early-onset bipolar affective disorder. Br. J. Psychiatry 1999, 174:121-127.
290. Sinclair D., Tsai S.Y., Woon H.G., Weickert C.S. Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness. Neuropsychopharmacology 2011, 36:2698-2709.
291. Singh M.K. Is there validity to the bipolar prodrome?. J. Clin. Psychiatry 2015, 76(e):655-656.
292. Singh M.K., DelBello M.P., Chang K.D. Neuroimaging Studies of Bipolar Disorder in Youth. The Bipolar Brain. Integrating Neuroimaging and Genetics 2012, 103-124. Oxford University Press, New York. S.M. Strakowski (Ed.).
293. Sklar P., Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
294. Sklar P., Psychiatric GWS Consortium Bipolar Disorder Working Group Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 2011, 43:977-983.
295. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., de Bakker P.I., Ogdie M.N., Thase M.E., Sachs G.S., Todd-Brown K., Gabriel S.B., Sougnez C., Gates C., Blumenstiel B., Defelice M., Ardlie K.G., Franklin J., Muir W.J., McGhee K.A., MacIntyre D.J., McLean A., VanBeck M., McQuillin A., Bass N.J., Robinson M., Lawrence J., Anjorin A., Curtis D., Scolnick E.M., Daly M.J., Blackwood D.H., Gurling H.M., Purcell S.M. Whole genome association study of bipolar disorder. Mol. Psychiatry 2008, 13:558-569.
296. Smallheiser N.R., Lugli G., Zhang H., Rizvi H., Cook E.H., Dwivedi Y. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One 2014, 9.
297. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of activin/nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008, 313:107-117.
298. Smith K.R., Kopeikina K.J., Fawcett-Patel J.M., Leaderbrand K., Gao R., Schürmann B., Myczek K., Radulovic J., Swanson G.T., Penzes P. Psychiatric risk factor ANK3/ankyrin-G nanodomains regulate the structure and function of glutamatergic synapses. Neuron 2012, 84:399-415.
299. Smrt R.D., Szulwach K.E., Pfeiffer R.L., Li X., Guo W., Pathania M., Zeng Z.Q., Luo Y., Peng J., Bordey A., Jin P., Zhao X. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010, 28:1060-1070.
300. Soares J.C., Mann J.J. The anatomy of mood disorders-revview of structural neuroimaging studies. Biol. Psychiatry 1997, 41:86-106.
301. Solís-Chagoyán H., Calixto E., Figueroa A., Montaño L.M., Berlanga C., Rodríguez-Verdugo M.S., Romo F., Jiménez M., Gurrola C.Z., Riquelme A., Benítez-King G. Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder. Schizophr. Res. 2013, 143:384-389.
302. Southwell D.G., Nicholas C.R., Basbaum A.I., Stryker M.P., Kriegstein A.R., Rubenstein J.L., Alvarez-Buylla A. Interneurons from embryonic development to cell-based therapy. Science 2014, 344. 10.1126/science.1240622.
303. Stevens H.E., Smith K.M., Rash B.G., Vaccarino F.M. Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front. Neurosci. 2010, (pii: 59).
304. Storm E.E., Garel S., Borello U., Hebert J.M., Martinez S., McConnell S.K., Martin G.R., Rubenstein J.L. Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers. Development 2006, 133:1831-1844.
305. Strakowski S.M. Integration and consolidation. A neurophysiological model of bipolar disorder. The Bipolar Brain. Integrating Neuroimaging and Genetics 2012, 253-274. Oxford University Press, New York. S.M. Strakowski (Ed.).
306. Strakowski S.M., DelBello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol. Psychiatry 2005, 56:105-116.
307. Strakowski S.M., DelBello M.P., Zimmerman M.E., Getz G.E., Mills N.P., Ret J., Shear P., Adler C.M. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am. J. Psychiatry 2002, 159:1841-1847.
308. Strakowski S.M., Wilson D.R., Tohen M., Woods B.T., Douglass A.W., Stoll A.L. Structural brain abnormalities in first-episode mania. Biol. Psychiatry 1993, 33:602-609.
309. Strazisar M., Cammaerts S., van der Ven K., Forero D.A., Lenaerts A.-S., Nordin A., Almeida-Souza L., Genovese G., Timmerman V., Liekens A., De Rijk P., Adolfsson R., Callaerts P., Del-Favero J. MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol. Psychiatry 2015, 20:472-481.
310. Subburaju S., Benes F.M. Induction of the GABA cell phenotype: an in vitro model for studying neurodevelopmental disorders. PLoS One 2012, 7.
311. Sugawara H., Iwamoto K., Bundo M., Ueda J., Miyauchi T., Komori A., Kazuno A., Adati N., Kusumi I., Okazaki Y., Ishigooka J., Kojima T., Kato T. Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Transcult. Psychiatry 2011, 1.
312. Sun X., Young L.T., Wang J.F., Grof P., Turecki G., Rouleau G.A., Alda M. Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology 2004, 29:799-804.
313. Sussel L., Marin O., Kimura S., Rubenstein J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal Telencephalon: evidence for a transformation of the pallidum into the striatum. Development 1999, 126:3359-3370.
314. Tabares-Seisdedos R., Escamex T., Martinez-Gimenez J.A., Balanza V., Salazar J., Selva G., Rubio C., Vieta E., Geijo-Barrientos E., Martinez-Aran A., Reiner O., Martinez S. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from Mediterranean Spain. A preliminary study. Neuroscience 2006, 139:1289-12300.
315. Tabares-Seisdedos R., Mata I., Escamez T., Vieta E., Lopez-IIundian J.M., Salazar J., Selva G., Balanza V., Rubio C., Martinez-Aran A., Valdes-Sanchez L., Geijo-Barrientos E., Martinez S. Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a spanish isolate population. Psychiatr. Genet. 2008, 18:313-317.
316. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
317. Takahashi T., Walterfang M., Wood S.J., Kempton M.J., Jogia J., Lorenzetti V., Soulsby B., Suzuki M., Velakoulis D., Pantelis C., Frangou S. Pituitary volume in patients with bipolar disorder and their first-degree relatives. J. Affect. Disord. 2010, 124:256-261.
318. Thompson P.M., Giedd J.N., Woods R.P., MacDonald D., Evans A.C., Toga A.W. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 2000, 404:190-193.
319. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
320. Tkachev D., Mimack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
321. Tohen M., Zarate C.A., Hennen J., Khalsa H.M., Strakowski S.M., Gebre-Medhin P., Salvatore P., Baldessarini R.J. The McLean-harvard first-episode mania study: prediction of recovery and first recurrence. Am. J. Psychiatry 2003, 160:2099-2107.
322. Torrey E.F. Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr. Res. 1999, 139:101-106.
323. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 2005, 57:252-260.
324. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seaonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28:1-38.
325. Trixler M., Tényi T., Csábi G., Szabó R. Minor physical anomalies in schizophrenia and bipolar affective disorder. Schizophr. Res. 2001, 52:195-201.
326. Tseng M., Alda M., Xu L., Sun X., Wang J.F., Grof P., Turecki G., Rouleaum G., Youngm L.T. BDNF protein levels are decreased in transformed lymphoblasts from lithium-responsive patients with bipolar disorder. J. Psychiatry Neurosci. 2008, 33:449-453.
327. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the stanley neuropathology consortium. Schizophr. Res. 2004, 67:269-275.
328. Uribe E., Wix R. Neuronal migration, apoptosis and bipolar disorder. Rev. Psiquiatr. Salud Ment. 2012, 5:127-133.
329. Valvezan A.J., Klein P.S. GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front. Mol. Neurosci. 2012, 5:1-13.
330. van der Schot A.C., Vonk R., Brans R.G., van Haren N.E., Koolschijn P.C., Nuboer V., Schnack H.G., van Baal G.C., Boomsma D.I., Nolen W.A., Hulshoff Pol H.E., Kahn R.S. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch.Gen. Psychiat. 2009, 66:142-1551.
331. van der Schot A.C., Vonk R., Brouwer R.M., van Baal G.C., Brans R.G., van Haren N.E., Schnack H.G., Boomsma D.I., Nolen W.A., Hulshoff Pol H.E., Kahn R.S. Genetic and environmental influences on focal brain density in bipolar disorder. Brain 2010, 133:3080-3092.
332. van Erp T.G., Thompson P.M., Kieseppä T., Bearden C.E., Marino A.C., Hoftman G.D., Haukka J., Partonen T., Huttunen M., Kaprio J., Lönnqvist J., Poutanen V.P., Toga A.W., Cannon T.D. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum. Brain Mapp. 2012, 233:501-510.
333. van Os J., Jones P., Lewis G., Wadsworth M., Murray R. Developmental precursors of affective illness in a general population birth cohort. Arch. Gen. Psychiatry 1997, 54:625-631.
334. Vawter M.P., Freed W.J., Kleinman J.E. Neuropathology of bipolar disorder. Biol. Psychiatry 2000, 48:486-504.
335. Vazin T., Freed W.J. Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor. Neurol. Neurosci. 2010, 28:589-603.
336. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
337. Viswanath B., Jose S.P., Squassina A., Thirthalli J., Purushottam M., Mukherjee O., Vladimirov V., Patrinos G.P., Del Zompo M., Jain S. Cellular models to study bipolar disorder: a systematic review. J. Affect. Disord. 2015, 184:36-50.
338. Vita A., De Peri L., Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009, 11:807-814.
339. Vocisano C., Klein D.N., Keefe R.S., Dienst E.R., Kincaid M.M. Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. Am. J. Psychiatry 1996, 153:248-255.
340. Walker R.M., Rybka J., Anderson S.M., Torrance H.S., Boxall R., Sussmann J.E., Porteous D.J., McIntosh A.M., Evans K.L. Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder. J. Psychiatr. Res. 2015, 62:48-55.
341. Walterfang M.A., Wood G., Barton S., Velakoulis D., Chen J., Reutens D.C., Kempton M.J., Haldane M., Panelis C., Frangou S. Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33:1050-1057.
342. Walton N.M., Zhou Y., Kogan J.H., Shin R., Webster M., Gross A.K., Heusner C.L., Chen Q., Miyake S., Tajinda K., Tamura K., Miyakawa T., Matsumoto M. Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients. Transcult. Psychiatry 2012, 2.
343. Wang J.L., Shamah S.M., Sun A.X., Waldman I.D., Haggarty S.J., Perlis R.H. Label-free, live optical imaging of reprogrammed bipolar disorder patient-derived cells reveals a functional correlate of lithium responsiveness. Transcult. Psychiatry 2014, 4.
344. Wang T., Zeng Z., Li T., Liu J., Li J., Li Y., Zhao Q., Wei Z., Wang Y., Li B., Feng G., He L., Shi Y. Common SNPs in myelin transcription factor 1-like (MYT1L): association with major depressive disorder in the Chinese Han population. PLoS One 2010, 5.
345. Wegbreit E., Cushman G.K., Puzia M.E., Weissman A.B., Kim K.L., Laird A.R., Dickstein D.P. Developmental meta-analyses of the functional neural correlates of bipolar disorder. JAMA Psychiatry 2014, 71:926-935.
346. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
347. Weisenbach S.L., Marshall D., Weldon A.L., Ryan K.A., Vederman A.C., Kamali M., Zubieta J.K., McInnis M.G., Langenecker S.A. The double burden of age and disease on cognition and quality of life in bipolar disorder. Int. J. Geriatr. Psychiatry 2014, 29:952-961.
348. Wen Z., Nguyen H.N., Guo Z., Lalli M.A., Wang X., Su Y., Kim N.S., Yoon K.J., Shin J., Zhang C., Makri G., Nauen D., Yu H., Guzman E., Chiang C.H., Yoritomo N., Kaibuchi K., Zou J., Christian K.M., Cheng L., Ross C.A., Margolis R.L., Chen G., Kosik K.S., Song H., Ming G.L. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 2014, 515:414-448.
349. Womer F.Y., Wang F., Chepenik L.G., Kalmar J.H., Spencer L., Edmiston E., Pittman B.P., Constable R.T., Papademetris X., Blumberg H.P. Sexually dimorphic features of vermis morphology in bipolar disorder. Bipolar Disord. 2009, 11:753-758.
350. Worland J., Hesselbrock V. The intelligence of children and their parents with schizophrenia and affective illness. J. Child Psychol. Psychiatry 1980, 21:191-201.
351. Wright C., Turner J., Calhoun V., Perrone-Bizzozero N. Potential impact of miR-137 and its targets in schizophrenia. Front. Genet. 2013, 4:58.
352. Xiao Y., Camarillo C., Ping Y., Arana T.B., Zhao H., Thompson P.M., Xu C., Su B.B., Fan H., Ordonez J., Wang L., Mao C., Zhang Y., Cruz D., Escamilla M.A., Li X., Xu C. The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS One 2014, 9.
353. Xu B., Hsu P.-K., Karayiorgou M., Gogos J.A. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol. Dis. 2012, 46:291-301.
354. Yanovsky-Dagan S., Avitzour M., Altarescu G., Renbaum P., Eldar-Geva T., Schonberger O., Mitrani-Rosenbaum S., Levy-Lahad E., Birnbaum R.Y., Gepstein L., Epsztejn-Litman S., Eiges R. Uncovering the role of hypermethylation by CTG expansion in myotonic dystrophy type 1 using mutant human embryonic stem cells. Stem Cell Rep. 2015, 5:221-231.
355. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations in the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006, 30:969-995.
356. Yokota Y., Gashghaei H.T., Han C., Watson H., Campbell K.J., Anton E.S. Radial glial dependent and independent dynamics of interneuronal migration in the developing cerebral cortex. PLoS One 2007, 2.
357. Yoshimizu T., Pan J.Q., Mungenast A.A.E., J.M., Su S., Ketterman J., Ongur D., McPhie D., Cohen B., Perlis R., Tsai L.H. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol. Psychiatry 2015, 20:162-169.
358. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
359. Yucel K., Taylor V.H., McKinnon M.C., Macdonald K., Alda M., Young L.T., MacQueen G.M. Bilateral hippocampal volume increase in patients with bipolar disorder and short term lithium treatment. Neuropsychopharmacology 2008, 33:361-367.
360. Zeschel E., Bechdolf A., Krüger-Oezguerdal S., Correll C.U., Leopold K., Pfennig A., Bauer M., Juckel G. Temperament and prodromal symptoms prior to first manic/hypomanic episodes: results from a pilot study. J. Affect. Disord. 2015, 173:39-44.
361. Zhang C., Wang Z., Hong W., Wu Z., Peng D., Fang Y. ZNF804A genetic variation confers risk to bipolar disorder. Mol. Neurobiol. 2015, (2015 May 3).
362. Zhang X., Xu R., Zhu B., Yang X., Ding X., Duan S., Xu T., Zhuang Y., Han M. Syne-1 and syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. Development 2007, 134:901-908.
363. Zhang Z., Convertini P., Shen M., Xu X., Lemoine F., de la Grange P., Andrees D.A., Stamm S. Valproic acid causes proteasomal degradation of DICER and influences miRNA expression. PLoS One 2013, 8.
364. Ziller M.J., Edri R., Yaffe Y., Donaghey J., Pop R., Mallard W., Issner R., Gifford C.A., Goren A., Xing J., Gu H., Cacchiarelli D., Tsankov A.M., Epstein C., Rinn J.L., Mikkelsen T.S., Kohlbacher O., Gnirke A., Bernstein B.E., Elkabetz Y., Meissner A. Dissecting neural differentiation regulatory networks through epigenetic footprinting. Nature 2015, 518:355-359.